Intal (sodium cromoglycate) therapy in ulcerative colitis.

Acta allergologica Pub Date : 1977-01-01
J Malolepszy, K Kuczymska-Sekieta, W Chachaj
{"title":"Intal (sodium cromoglycate) therapy in ulcerative colitis.","authors":"J Malolepszy,&nbsp;K Kuczymska-Sekieta,&nbsp;W Chachaj","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Intal was applied intrarectally for the treatment of ulcerative colitis in 39 patients with active pathological process. The drug was insufflated by means of rectoscopic tube at the dosage of 200 mg capsules daily for 15 days. Complete remission of the disease has been achieved in 97 per cent of patients within 2 weeks of the administration of the drug. As a maintenance treatment the patients were given SCG orally (240 mg daily) for a period of 2--3 years. During the course of 2--3 years' observation 93 per cent of patients have been maintained in remission by oral SCG therapy.</p>","PeriodicalId":75372,"journal":{"name":"Acta allergologica","volume":"Suppl 13 ","pages":"82-6"},"PeriodicalIF":0.0000,"publicationDate":"1977-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta allergologica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Intal was applied intrarectally for the treatment of ulcerative colitis in 39 patients with active pathological process. The drug was insufflated by means of rectoscopic tube at the dosage of 200 mg capsules daily for 15 days. Complete remission of the disease has been achieved in 97 per cent of patients within 2 weeks of the administration of the drug. As a maintenance treatment the patients were given SCG orally (240 mg daily) for a period of 2--3 years. During the course of 2--3 years' observation 93 per cent of patients have been maintained in remission by oral SCG therapy.

溃疡性结肠炎的初始治疗。
对39例病理过程活跃的溃疡性结肠炎患者应用本品进行直肠内治疗。经直肠镜插管给药,每日200 mg胶囊,连用15天。97%的患者在服用该药后两周内病情完全缓解。作为维持治疗,患者口服SCG(每天240毫克),持续2- 3年。在2- 3年的观察过程中,93%的患者通过口服SCG治疗维持缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信